Systemic sclerosis and the heart

Heart disease, either clinically apparent or silent, is a frequent complication of systemic sclerosis (SSc, scleroderma) and may affect both patients with diffuse cutaneous and limited cutaneous SSc. The availability of more sensitive modalities has led to an increased awareness of scleroderma heart...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Rheumatic diseases clinics of North America Ročník 40; číslo 1; s. 87
Hlavní autori: Parks, John L, Taylor, Marian H, Parks, Laura P, Silver, Richard M
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.02.2014
Predmet:
Cardiomyopathies - etiology
Heart Diseases - diagnosis
Heart Diseases - etiology
Heart Diseases - therapy
Heart Valve Diseases - etiology
Humans
Prognosis
Scleroderma, Systemic - complications
Ventricular Dysfunction - etiology
Pericarditis
Myocardial fibrosis
Conduction abnormalities
Scleroderma
Heart disease
Systemic sclerosis
ISSN:1558-3163, 1558-3163
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Heart disease, either clinically apparent or silent, is a frequent complication of systemic sclerosis (SSc, scleroderma) and may affect both patients with diffuse cutaneous and limited cutaneous SSc. The availability of more sensitive modalities has led to an increased awareness of scleroderma heart disease, which often involves the pericardium, myocardium, and cardiac conduction system. This awareness of cardiac involvement requires attention and interventions led by internists, cardiologists, and rheumatologists. Although no specific therapy exists for scleroderma heart disease, early recognition of the presence and type of scleroderma heart disease may lead to more effective management of patients with scleroderma.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1558-3163
1558-3163
DOI:10.1016/j.rdc.2013.10.007